{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T05:53:20Z","timestamp":1787896400740,"version":"build-2784847793"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C02099"],"award-info":[{"award-number":["2025C02099"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cca.2025.120176","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:56:47Z","timestamp":1738688207000},"page":"120176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review"],"prefix":"10.1016","volume":"569","author":[{"given":"Mengting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongsen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.cca.2025.120176_b0005","first-page":"752","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment","volume":"164","author":"Stoffel","year":"2023","journal-title":"Early Detection, and Prevention, Gastroenterology"},{"key":"10.1016\/j.cca.2025.120176_b0010","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semcancer.2020.08.003","article-title":"Germline genetic variability in pancreatic cancer risk and prognosis","volume":"79","author":"Gentiluomo","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0015","first-page":"1234","article-title":"Lipid metabolism in pancreatic cancer: emerging roles and potential targets","volume":"42","author":"Yin","year":"2022","journal-title":"CancerCommun. (Lond)"},{"issue":"7","key":"10.1016\/j.cca.2025.120176_b0020","article-title":"Smad4 Deficiency promotes pancreatic cancer immunogenicity by activating the cancer-autonomous DNA-sensing signaling axis","volume":"9","author":"Xiong","year":"2022","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0025","article-title":"The potential roles of p53 signaling reactivation in pancreatic cancer therapy","volume":"1877","author":"Ou","year":"2022","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1158\/0008-5472.CAN-23-1542","article-title":"Mesothelin secretion by pancreatic cancer cells co-opts macrophages and promotes metastasis","volume":"84","author":"Luckett","year":"2024","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41568-021-00383-9","article-title":"The immunological and metabolic landscape in primary and metastatic liver cancer","volume":"21","author":"Li","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.cca.2025.120176_b0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071066","article-title":"Metabolic reprogramming and its relationship to survival in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.cca.2025.120176_b0045","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.cgh.2019.11.043","article-title":"New-Onset diabetes, longitudinal trends inmetabolicmarkers, and risk of pancreatic cancer in aheterogeneous population","volume":"18","author":"Huang","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123635","article-title":"A novel four-gene score to predict pathologically complete (R0) resection and survival in pancreatic cancer","volume":"12","author":"Oshi","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0055","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12935-022-02730-8","article-title":"Prediction of hepatocellular carcinoma prognosis and immunotherapeutic effects based on tryptophan metabolism-related genes","volume":"22","author":"Xue","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"14","key":"10.1016\/j.cca.2025.120176_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143403","article-title":"Association between temporal glycemic change and risk of pancreatic cancer in men: a prospective cohort study","volume":"14","author":"Cai","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.cca.2025.120176_b0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41419-023-06032-3","article-title":"The role of epithelial-mesenchymal transition and autophagy in pancreatic ductal adenocarcinoma invasion","volume":"14","author":"Yang","year":"2023","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0075","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.7150\/ijbs.67675","article-title":"Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression","volume":"18","author":"Chen","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"11","key":"10.1016\/j.cca.2025.120176_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14112810","article-title":"Multiparametric phenotyping of circulating tumor cells for analysis of therapeutic targets, oncogenic signaling pathways and DNA repair markers","volume":"14","author":"Staudte","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41392-021-00817-8","article-title":"Circulating tumor cells: biology and clinical significance","volume":"6","author":"Lin","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41392-022-01057-0","article-title":"Targeting HECTD3-IKK\u03b1 axis inhibits inflammation-related metastasis","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"6","key":"10.1016\/j.cca.2025.120176_b0095","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1078-0432.CCR-15-1615","article-title":"Mutant p53 together with TGF\u03b2 signaling influence organ-specific hematogenous colonization patterns of pancreatic cancer","volume":"23","author":"Zhong","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120176_b0100","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1007\/BF02574475","article-title":"Role of angiogenesis in the development and growth of liver metastasis","volume":"9","author":"Takeda","year":"2002","journal-title":"Ann. Surg. Oncol."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14123028","article-title":"The liver pre-metastatic niche in pancreatic cancer: a potential opportunity for intervention","volume":"14","author":"Gumberger","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2025.120176_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120680","article-title":"Regulation of tumor microenvironment for pancreatic cancer therapy","volume":"270","author":"Huang","year":"2021","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1158\/2159-8290.CD-22-0876","article-title":"Context-Specific determinants of the immunosuppressive tumor microenvironment in pancreatic cancer","volume":"13","author":"Falcomat\u00e0","year":"2023","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0120","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s10555-021-09988-w","article-title":"The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions","volume":"40","author":"Herting","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"13","key":"10.1016\/j.cca.2025.120176_b0125","doi-asserted-by":"crossref","first-page":"5778","DOI":"10.7150\/thno.41409","article-title":"Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents","volume":"10","author":"Roy","year":"2020","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.cca.2025.120176_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201905500","article-title":"A biomimetic tumor model of heterogeneous invasion in pancreatic ductal adenocarcinoma","volume":"16","author":"Bradney","year":"2020","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0135","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","article-title":"Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cca.2025.120176_b0140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor microenvironment in pancreatic cancer pathogenesis and therapeutic resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cca.2025.120176_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1258538","article-title":"An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancer","volume":"14","author":"Guo","year":"2023","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cca.2025.120176_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081082","article-title":"Epigenetic alterations in pancreatic cancer metastasis","volume":"11","author":"Wang","year":"2021","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.cca.2025.120176_b0155","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00535-022-01915-2","article-title":"Epigenetic regulation of pancreatic adenocarcinoma in the era of cancer immunotherapy","volume":"57","author":"Kawakubo","year":"2022","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.cca.2025.120176_b0160","doi-asserted-by":"crossref","first-page":"13563","DOI":"10.1038\/srep13563","article-title":"Clinicopathological significance of CDKN2A promoter hypermethylation frequency with pancreatic cancer","volume":"5","author":"Tang","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.hbpd.2020.03.010","article-title":"Differential methylation landscape of pancreatic ductal adenocarcinoma and its precancerous lesions","volume":"19","author":"Bararia","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0170","article-title":"Histone deacetylases: a novel class of therapeutic targets for pancreatic cancer","volume":"1877","author":"Xiang","year":"2022","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0175","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.7150\/ijbs.91613","article-title":"MiR-21-mediated metabolic alteration of cancer-associated fibroblasts and its effect on pancreatic cancer cell behavior: retraction","volume":"20","author":"Chen","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0180","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/s41419-018-1182-9","article-title":"miR-21 promotes EGF-induced pancreatic cancer cell proliferation by targeting Spry2","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0185","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.3892\/or.2013.2576","article-title":"Regulation of miR-155 affects pancreatic cancer cell invasiveness and migration by modulating the STAT3 signaling pathway through SOCS1","volume":"30","author":"Huang","year":"2013","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40291-023-00641-6","article-title":"The diagnostic and prognostic value of miR-155 in cancers: an updated meta-analysis","volume":"27","author":"Wu","year":"2023","journal-title":"Mol. Diagn. Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0195","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/21541264.2021.1922071","article-title":"Long noncoding RNAs: role and contribution in pancreatic cancer","volume":"12","author":"Ramya Devi","year":"2021","journal-title":"Transcription"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0200","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.stem.2023.11.011","article-title":"A pancreatic cancer organoid platform identifies an inhibitor specific to mutant KRAS","volume":"31","author":"Duan","year":"2024","journal-title":"Cell Stem. Cell"},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0205","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10555-021-09990-2","article-title":"Targeting KRAS in pancreatic cancer: new drugs on the horizon","volume":"40","author":"Bannoura","year":"2021","journal-title":"Cancer Metastasis Rev."},{"issue":"8","key":"10.1016\/j.cca.2025.120176_b0210","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1158\/1078-0432.CCR-14-2425","article-title":"Metabolic dependencies in RAS-driven cancers","volume":"21","author":"Kimmelman","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0215","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/s41467-021-21736-w","article-title":"KRAS drives immune evasion in a genetic model of pancreatic cancer","volume":"12","author":"Ischenko","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.cca.2025.120176_b0220","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1038\/s41416-023-02189-y","article-title":"Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer","volume":"128","author":"Umemoto","year":"2023","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.cca.2025.120176_b0225","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of resistance to oncogenic KRAS inhibition in pancreatic cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cca.2025.120176_b0230","unstructured":"Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma, Cancer Cell 32(2) (2017) 185-203.e13."},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41418-018-0246-9","article-title":"Mutant p53 as a guardian of the cancer cell","volume":"26","author":"Mantovani","year":"2019","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0240","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1101\/gad.212282.112","article-title":"Global genomic profiling reveals an extensive p53-regulated autophagy program contributing to key p53 responses","volume":"27","author":"Kenzelmann Broz","year":"2013","journal-title":"Genes Dev."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0245","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1136\/gutjnl-2016-313317","article-title":"A genetic roadmap of pancreatic cancer: still evolving","volume":"66","author":"Notta","year":"2017","journal-title":"Gut."},{"key":"10.1016\/j.cca.2025.120176_b0250","article-title":"Opposite roles of tumor cell proliferation and immune cell infiltration in postoperative liver metastasis of PDAC","volume":"9","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13045-020-00958-3","article-title":"Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Qian","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0260","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/cimb46040177","article-title":"Significance of TP53, CDKN2A, SMAD4 and KRAS in pancreatic cancer","volume":"46","author":"Stefanoudakis","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0265","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrc.2016.66","article-title":"Pancreatic cancer biology and genetics from an evolutionary perspective","volume":"16","author":"Makohon-Moore","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cca.2025.120176_b0270","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.844527","article-title":"Molecular landscape and prognostic biomarker analysis of advanced pancreatic cancer and predictors of treatment efficacy of AG chemotherapy","volume":"12","author":"Du","year":"2022","journal-title":"Front Oncol."},{"issue":"7","key":"10.1016\/j.cca.2025.120176_b0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","article-title":"Contextual determinants of TGF\u03b2 action in development, immunity and cancer","volume":"19","author":"David","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0280","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","article-title":"Transforming growth factor-\u03b2 signaling in immunity and cancer","volume":"50","author":"Batlle","year":"2019","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0285","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13238-020-00760-4","article-title":"Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation","volume":"12","author":"Wang","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.cca.2025.120176_b0290","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.785400","article-title":"Successful immunotherapy for pancreatic cancer in a patient with TSC2 and SMAD4 mutations: a case report","volume":"12","author":"Ye","year":"2021","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0295","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041040","article-title":"E-cadherin in pancreatic ductal adenocarcinoma: a multifaceted actor during EMT","volume":"9","author":"Sommariva","year":"2020","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0300","first-page":"191","article-title":"E-cadherin: an enigma in pancreatic diseases","volume":"9","author":"Garrido","year":"2020","journal-title":"CellMol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cca.2025.120176_b0305","article-title":"Prognostic and clinicopathological significance of E-cadherin in pancreatic cancer patients: a meta-analysis","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.cca.2025.120176_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109320","article-title":"Aberrant N-cadherin expression in cancer","volume":"118","author":"Cao","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"24","key":"10.1016\/j.cca.2025.120176_b0315","doi-asserted-by":"crossref","first-page":"11745","DOI":"10.1158\/0008-5472.CAN-06-2322","article-title":"Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and up-regulating N-cadherin expression","volume":"66","author":"Shintani","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0320","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10555-023-10154-7","article-title":"Targeting vimentin: a multifaceted approach to combatting cancer metastasis and drug resistance","volume":"43","author":"Tabatabaee","year":"2024","journal-title":"Cancer Metastasis Rev."},{"issue":"13","key":"10.1016\/j.cca.2025.120176_b0325","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1245\/s10434-019-07891-x","article-title":"Vimentin expression in tumor microenvironment predicts survival in pancreatic ductal adenocarcinoma: heterogeneity in fibroblast population","volume":"26","author":"Maehira","year":"2019","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.cca.2025.120176_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1008075","article-title":"G-quadruplexes formation within the promoter of TEAD4 oncogene and their interaction with Vimentin","volume":"10","author":"Cozzaglio","year":"2022","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0335","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200388","article-title":"Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer","volume":"217","author":"Recouvreux","year":"2020","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0340","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s41392-023-01478-5","article-title":"BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.cca.2025.120176_b0345","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cca.2025.120176_b0350","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1476-4598-2-12","article-title":"Influence of hypoxia and neoangiogenesis on the growth of pancreatic cancer","volume":"2","author":"Duffy","year":"2003","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2025.120176_b0355","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.683788","article-title":"Targeting growth factor signaling pathways in pancreatic cancer: towards inhibiting chemoresistance","volume":"11","author":"Xelwa","year":"2021","journal-title":"Front Oncol."},{"issue":"10","key":"10.1016\/j.cca.2025.120176_b0360","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V","article-title":"High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma","volume":"88","author":"Seo","year":"2000","journal-title":"Cancer"},{"issue":"46","key":"10.1016\/j.cca.2025.120176_b0365","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6764","article-title":"Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy","volume":"6","author":"Xin","year":"2020","journal-title":"Sci. Adv."},{"issue":"10","key":"10.1016\/j.cca.2025.120176_b0370","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026507118","article-title":"Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis","volume":"118","author":"Mrouj","year":"2021","journal-title":"PNAS"},{"key":"10.1016\/j.cca.2025.120176_b0375","doi-asserted-by":"crossref","DOI":"10.20892\/j.issn.2095-3941.2023.0363","article-title":"Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma","author":"Liang","year":"2024","journal-title":"Cancer Biol. Med."},{"issue":"5","key":"10.1016\/j.cca.2025.120176_b0380","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs5.50175","article-title":"Prognostic impact of Ki-67 proliferative index in resectable pancreatic ductal adenocarcinoma","volume":"3","author":"Pergolini","year":"2019","journal-title":"BJS Open"},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0385","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/SLA.0000000000003022","article-title":"Genetic analysis of small well-differentiated pancreatic neuroendocrine tumors identifies subgroups with differing risks of liver metastases","volume":"271","author":"Pea","year":"2020","journal-title":"Ann. Surg."},{"issue":"38","key":"10.1016\/j.cca.2025.120176_b0390","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1038\/s41388-021-01951-x","article-title":"MASTL regulates EGFR signaling to impact pancreatic cancer progression","volume":"40","author":"Fatima","year":"2021","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0395","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/annonc\/mdl175","article-title":"Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer","volume":"18","author":"Cruz","year":"2007","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.cca.2025.120176_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0405","article-title":"Roles of CA19-9 in pancreatic cancer: biomarker, predictor and promoter","volume":"1875","author":"Luo","year":"2021","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0410","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12957-017-1175-7","article-title":"Risk factors of liver metastasis from advanced pancreatic adenocarcinoma: a large multicenter cohort study","volume":"15","author":"S","year":"2017","journal-title":"World J. Surg. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0415","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3892\/mco.2022.2559","article-title":"Prognostic value of serum CEA and CA19-9 levels in pancreatic ductal adenocarcinoma","volume":"17","author":"Ermiah","year":"2022","journal-title":"Mol. Clin. Oncol"},{"key":"10.1016\/j.cca.2025.120176_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.662010","article-title":"The expression of PD-L1 and B7-H4 in thymic epithelial tumor and its relationship with tumor immune-infiltrating cells","volume":"11","author":"Yan","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.cca.2025.120176_b0425","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.2147\/OTT.S146383","article-title":"Prognostic value of PD-L1 overexpression for pancreatic cancer: evidence from a meta-analysis","volume":"10","author":"Zhuan-Sun","year":"2017","journal-title":"Onco Targets Ther."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0430","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-023-01813-y","article-title":"Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma","volume":"22","author":"Gautam","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cca.2025.120176_b0435","article-title":"The interplay between inflammation and stromal components in pancreatic cancer","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol."},{"key":"10.1016\/j.cca.2025.120176_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1023177","article-title":"The role of IL-6\/JAK2\/STAT3 signaling pathway in cancers","volume":"12","author":"Huang","year":"2022","journal-title":"Front. Oncol."},{"issue":"22","key":"10.1016\/j.cca.2025.120176_b0445","doi-asserted-by":"crossref","DOI":"10.3390\/cells11223698","article-title":"The role of IL-6 in cancer cell invasiveness and metastasis-overview and therapeutic opportunities","volume":"11","author":"Ra\u0161kov\u00e1","year":"2022","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0450","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092116","article-title":"Inflammatory cytokine: an attractive target for cancer treatment","volume":"10","author":"Lee","year":"2022","journal-title":"Biomedicines"},{"issue":"13","key":"10.1016\/j.cca.2025.120176_b0455","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14133263","article-title":"Regulation and function of matrix metalloproteinase-13 in cancer progression and metastasis","volume":"14","author":"Li","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"43","key":"10.1016\/j.cca.2025.120176_b0460","doi-asserted-by":"crossref","first-page":"74406","DOI":"10.18632\/oncotarget.20160","article-title":"Tenascin-C induces migration and invasion through JNK\/c-Jun signalling in pancreatic cancer","volume":"8","author":"Cai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2025.120176_b0465","article-title":"C-reactive protein is a prognostic biomarker in pancreatic ductal adenocarcinoma patients","author":"Bonazzi","year":"2023","journal-title":"Asia Pac J. Clin. Oncol."},{"key":"10.1016\/j.cca.2025.120176_b0470","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.595835","article-title":"C-reactive protein and cancer-diagnostic and therapeutic insights","volume":"11","author":"Hart","year":"2020","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.cca.2025.120176_b0475","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1111\/jcmm.14984","article-title":"High-fat diet-induced dysbiosis mediates MCP-1\/CCR2 axis-dependent M2 macrophage polarization and promotes intestinal adenoma-adenocarcinoma sequence","volume":"24","author":"Liu","year":"2020","journal-title":"J. Cell Mol. Med."},{"issue":"19","key":"10.1016\/j.cca.2025.120176_b0480","doi-asserted-by":"crossref","first-page":"28697","DOI":"10.18632\/oncotarget.7376","article-title":"Targeting the CCL2-CCR2 signaling axis in cancer metastasis","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.cca.2025.120176_b0485","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1158\/1078-0432.CCR-13-0525","article-title":"Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2\/CCR2 axis","volume":"19","author":"Sanford","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"16","key":"10.1016\/j.cca.2025.120176_b0490","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168530","article-title":"Roles of CCL2-CCR2 axis in the tumor microenvironment","volume":"22","author":"Kadomoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cca.2025.120176_b0495","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0500","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14010086","article-title":"CXCL12 in pancreatic cancer: its function and potential as a therapeutic drug target","volume":"14","author":"Malik","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.cca.2025.120176_b0505","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1154581","article-title":"The role of CXCL12 axis in pancreatic cancer: new biomarkers and potential targets","volume":"13","author":"Roberto","year":"2023","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0510","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00261-020-02676-3","article-title":"S100A4 overexpression in pancreatic ductal adenocarcinoma: imaging biomarkers from whole-tumor evaluation with MRI and texture analysis","volume":"46","author":"Liang","year":"2021","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.cca.2025.120176_b0515","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8137378","article-title":"Impact of S100A4 expression on clinicopathological characteristics and prognosis in pancreatic cancer: a meta-analysis","volume":"2016","author":"Huang","year":"2016","journal-title":"Dis. Markers"},{"issue":"5","key":"10.1016\/j.cca.2025.120176_b0520","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41418-023-01126-z","article-title":"S100 family proteins are linked to organoid morphology and EMT in pancreatic cancer","volume":"30","author":"Low","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0525","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1038\/s41467-023-38064-w","article-title":"HAPLN1 potentiates peritoneal metastasis in pancreatic cancer","volume":"14","author":"Wiedmann","year":"2023","journal-title":"Nat. Commun."},{"issue":"7754","key":"10.1016\/j.cca.2025.120176_b0530","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-019-1130-6","article-title":"Targeting LIF-mediated paracrine interaction for pancreatic cancer therapy and monitoring","volume":"569","author":"Shi","year":"2019","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cca.2025.120176_b0535","doi-asserted-by":"crossref","DOI":"10.3390\/cells8020081","article-title":"Tumor extracellular matrix remodeling: new perspectives as a circulating tool in the diagnosis and prognosis of solid tumors","volume":"8","author":"Giussani","year":"2019","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0540","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00005-021-00605-w","article-title":"Leukemia inhibitory factor: A potential biomarker and therapeutic target in pancreatic cancer","volume":"69","author":"Wrona","year":"2021","journal-title":"Arch Immunol. Ther. Exp. (warsz)"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0545","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12929-022-00888-x","article-title":"Periostin promotes ovarian cancer metastasis by enhancing M2 macrophages and cancer-associated fibroblasts via integrin-mediated NF-\u03baB and TGF-\u03b22 signaling","volume":"29","author":"Lin","year":"2022","journal-title":"J. Biomed. Sci."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0550","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/ijc.23332","article-title":"Periostin, secreted from stromal cells, has biphasic effect on cell migration and correlates with the epithelial to mesenchymal transition of human pancreatic cancer cells","volume":"122","author":"Kanno","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0555","first-page":"709","article-title":"Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer","volume":"25","author":"Ben","year":"2011","journal-title":"Oncol. Rep."},{"issue":"9","key":"10.1016\/j.cca.2025.120176_b0560","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"7559","key":"10.1016\/j.cca.2025.120176_b0565","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cca.2025.120176_b0570","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-cellbio-101011-155750","article-title":"Functional diversity of laminins","volume":"28","author":"Domogatskaya","year":"2012","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0575","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-022-02516-w","article-title":"LAMC2 marks a tumor-initiating cell population with an aggressive signature in pancreatic cancer","volume":"41","author":"Cave","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.cca.2025.120176_b0580","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00018-022-04392-1","article-title":"Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR\/ERK1\/2\/AKT\/mTOR cascade","volume":"79","author":"Kirtonia","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"1\u20132","key":"10.1016\/j.cca.2025.120176_b0585","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.canlet.2014.04.017","article-title":"LRH1 promotes pancreatic cancer metastasis","volume":"350","author":"Lin","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cca.2025.120176_b0590","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.643522","article-title":"LRH1 acts as an oncogenic driver in human osteosarcoma and pan-cancer","volume":"9","author":"Song","year":"2021","journal-title":"Front Cell Dev. Biol."},{"issue":"29","key":"10.1016\/j.cca.2025.120176_b0595","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.3748\/wjg.v23.i29.5266","article-title":"Contribution of galectin-1, a glycan-binding protein, to gastrointestinal tumor progression","volume":"23","author":"Bacigalupo","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cca.2025.120176_b0600","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2017.03.024","article-title":"Galectin-1-driven upregulation of SDF-1 in pancreatic stellate cells promotes pancreatic cancer metastasis","volume":"397","author":"Qian","year":"2017","journal-title":"Cancer Lett."},{"issue":"16","key":"10.1016\/j.cca.2025.120176_b0605","doi-asserted-by":"crossref","first-page":"E3769","DOI":"10.1073\/pnas.1722434115","article-title":"Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk","volume":"115","author":"Orozco","year":"2018","journal-title":"PNAS"},{"key":"10.1016\/j.cca.2025.120176_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113300","article-title":"Proteomic analysis of metastasis-specific biomarkers in pancreatic cancer: galectin-1 plays an important metastatic role in pancreatic cancer","volume":"186","author":"Tung","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"17","key":"10.1016\/j.cca.2025.120176_b0615","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/s41388-024-02991-9","article-title":"tiRNA-Val-CAC-2 interacts with FUBP1 to promote pancreatic cancer metastasis by activating c\u2011MYC transcription","volume":"43","author":"Xiong","year":"2024","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.cca.2025.120176_b0620","doi-asserted-by":"crossref","first-page":"796","DOI":"10.21037\/hbsn-20-383","article-title":"Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice","volume":"10","author":"Zhao","year":"2021","journal-title":"Hepatobiliary Surg Nutr."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0625","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1007\/s13277-013-1327-5","article-title":"Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis","volume":"35","author":"Han","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.cca.2025.120176_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101321","article-title":"Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma","volume":"16","author":"Kim","year":"2022","journal-title":"Transl. Oncol."},{"issue":"6","key":"10.1016\/j.cca.2025.120176_b0635","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.ejso.2017.01.241","article-title":"Clinical impact of circulating tumor cells and therapy response in pancreatic cancer","volume":"43","author":"Okubo","year":"2017","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.cca.2025.120176_b0640","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jnci\/djad218","article-title":"Exposure to polycyclic aromatic hydrocarbons, volatile organic compounds, and tobacco-specific nitrosamines and incidence of esophageal cancer","volume":"116","author":"Etemadi","year":"2024","journal-title":"J. Natl Cancer Inst."},{"issue":"6","key":"10.1016\/j.cca.2025.120176_b0645","article-title":"Volatile organic compounds for early detection of prostate cancer from urine","volume":"9","author":"Liu","year":"2023","journal-title":"Heliyon"},{"issue":"11","key":"10.1016\/j.cca.2025.120176_b0650","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/bjs.10909","article-title":"Profile of exhaled-breath volatile organic compounds to diagnose pancreatic cancer","volume":"105","author":"Markar","year":"2018","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0655","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1186\/s12885-018-4452-0","article-title":"Pancreatic ductal adenocarcinoma can be detected by analysis of volatile organic compounds (VOCs) in alveolar air","volume":"18","author":"Princivalle","year":"2018","journal-title":"BMC Cancer"},{"issue":"24","key":"10.1016\/j.cca.2025.120176_b0660","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1039\/C6LC01063F","article-title":"Review: imaging technologies for flow cytometry","volume":"16","author":"Han","year":"2016","journal-title":"Lab Chip"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0665","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12967-024-04989-z","article-title":"High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study","volume":"22","author":"Huang","year":"2024","journal-title":"J. Transl. Med."},{"issue":"12","key":"10.1016\/j.cca.2025.120176_b0670","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/ijc.33969","article-title":"Clinical and molecular characteristics of estrogen receptor-positive ultralow risk breast cancer tumors identified by the 70-gene signature","volume":"150","author":"Johansson","year":"2022","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0675","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12885-021-08204-w","article-title":"Dynamic change of serum CA19-9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas","volume":"21","author":"Zhao","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0680","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-022-00403-2","article-title":"Detection of circulating tumor cells: opportunities and challenges","volume":"10","author":"Ju","year":"2022","journal-title":"Biomark Res."},{"issue":"1","key":"10.1016\/j.cca.2025.120176_b0685","doi-asserted-by":"crossref","DOI":"10.1093\/biomethods\/bpz014","article-title":"Digging deeper into volatile organic compounds associated with cancer","volume":"4","author":"Janfaza","year":"2019","journal-title":"Biol. Methods Protoc."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T23:11:06Z","timestamp":1740697866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":137,"alternative-id":["S0009898125000555"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120176","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive biomarkers of pancreatic cancer metastasis: A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120176","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120176"}}